Pay in 4 interest-free payments of $27.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
KD025 (200 mg/kg
which is not seen in cancer cells treated only with rapamycin
UNC1215 can serve as a useful chemical tool to interrogate the functions of MBT proteins and probe methyl-lysine reader proteins as a target class
PubMed PMID: 26738988
also known CMP 6 or JAK Inhibitor I
CPI-0610 - CAS# 1380087-89-7 0215 KD025 (200 mg/kgCPI 0610, also known as Pelabresib, CAS No. 1380087 89 7, is a small molecule inhibitor of the Bromodomain and Extra Terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the BET inhibitor CPI 0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling
US$ 25.00
US$ 6760.04
US$ 25.00
US$ 120.00
US$ 22.95
US$ 2382.00
US$ 115.00
US$ 32.00